These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7509486)

  • 41. Feedback microwave thermotherapy with the ProstaLund Compact Device for obstructive benign prostatic hyperplasia: 12-month response rates and complications.
    Alivizatos G; Ferakis N; Mitropoulos D; Skolarikos A; Livadas K; Kastriotis I
    J Endourol; 2005; 19(1):72-8. PubMed ID: 15735388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostatic stents for the treatment of benign prostatic hyperplasia.
    Vanderbrink BA; Rastinehad AR; Badlani GH
    Curr Opin Urol; 2007 Jan; 17(1):1-6. PubMed ID: 17143103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prevention of temporary prostatic obstruction after high-energy microwave thermothery by placement of prostatic bridge catheter].
    Djavan B; Seitz C; Fakhari M; Ghawidel K; Marberger M
    Prog Urol; 1999 Apr; 9(2):261-70. PubMed ID: 10370950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiofrequency heat-treatment to the prostate for bladder outlet obstruction associated with benign prostatic hyperplasia: a 4-year outcome study.
    Dawkins GP; Harrison NW; Ansell W
    Br J Urol; 1997 Jun; 79(6):910-4. PubMed ID: 9202558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term followup of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study.
    Floratos DL; Kiemeney LA; Rossi C; Kortmann BB; Debruyne FM; de La Rosette JJ
    J Urol; 2001 May; 165(5):1533-8. PubMed ID: 11342912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-energy transurethral microwave thermotherapy: symptomatic vs urodynamic success.
    Osman Y; Wadie B; El-Diasty T; Larson T
    BJU Int; 2003 Mar; 91(4):365-70. PubMed ID: 12603416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Benign prostatic hypertrophy treatment by transurethral radiofrequency hyperthermia with Thermex II.
    Viguier JL; Dessouki T; Castelo A; Martin X; Maréchal JM; Gelet A; Dubernard JM
    Eur Urol; 1993; 23(2):318-21. PubMed ID: 7683994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of intraprostatic temperature-controlled microwave thermotherapy in patients with benign prostatic hyperplasia: results of a prospective, open-label, single-center study with 1-year follow-up.
    Gravas S; Laguna MP; de la Rosette JJ
    J Endourol; 2003 Aug; 17(6):425-30. PubMed ID: 12965071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The UroLume stent in the management of benign prostatic hyperplasia.
    Milroy E; Chapple CR
    J Urol; 1993 Nov; 150(5 Pt 2):1630-5. PubMed ID: 7692100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transurethral microwave thermotherapy versus transurethral resection for symptomatic benign prostatic obstruction: a prospective randomized study with a 2-year follow-up.
    Dahlstrand C; Waldén M; Geirsson G; Pettersson S
    Br J Urol; 1995 Nov; 76(5):614-8. PubMed ID: 8535682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transurethral microwave thermotherapy for uncomplicated benign prostatic hyperplasia. A prospective study with emphasis on symptomatic improvement and complications.
    Marteinsson VT; Due J
    Scand J Urol Nephrol; 1994 Mar; 28(1):83-9. PubMed ID: 7516577
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transurethral radio frequency thermotherapy for symptomatic benign prostatic hyperplasia.
    Corica A; Marianetti A; Anchelerguez R; Pratts J; Corica L; Grau D; Nigro E; Filice R
    Eur Urol; 1993; 23(2):312-7. PubMed ID: 7683993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Transrectal hyperthermia in the treatment of benign prostatic hyperplasia].
    Wang X; Hou S; Zhu J
    Zhonghua Wai Ke Za Zhi; 1995 Feb; 33(2):115-6. PubMed ID: 7544716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transurethral interstitial laser coagulation for benign prostatic hyperplasia: treatment outcome and quality of life.
    Arai Y; Ishitoya S; Okubo K; Suzuki Y
    Br J Urol; 1996 Jul; 78(1):93-8. PubMed ID: 8795408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The titanium intraprostatic stent: the United States experience.
    Kaplan SA; Merrill DC; Mosely WG; Benson RC; Chiou RK; Fuselier HA; Parra RO
    J Urol; 1993 Nov; 150(5 Pt 2):1624-9. PubMed ID: 7692099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction.
    Rosario DJ; Woo H; Potts KL; Cutinha PE; Hastie KJ; Chapple CR
    Br J Urol; 1997 Oct; 80(4):579-86. PubMed ID: 9352697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transurethral balloon laser thermotherapy for urinary retention in patients with benign prostatic hyperplasia who are at high surgical risk.
    Furuya S; Ogura H; Tanaka Y; Tsukamoto T; Daikuzono N; Liong ML
    Int J Urol; 1997 May; 4(3):265-8. PubMed ID: 9255664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bipolar plasmakinetic transurethral resection of prostate in 132 consecutive patients with large gland: three-year follow-up results.
    Zhu G; Xie C; Wang X; Tang X
    Urology; 2012 Feb; 79(2):397-402. PubMed ID: 22035765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostakath in urinary outflow obstruction.
    Ala-Opas M; Talja M; Tiitinen J; Hellström P; Heikkinen A; Nurmi M
    Ann Chir Gynaecol Suppl; 1993; 206():14-8. PubMed ID: 7507307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical experience of local thermotherapy in the treatment of benign prostatic hyperplasia].
    Yoshii S; Fuzii T; Saitoh T; Yamamoto R; Ishida N; Hosoi Y; Tahara M
    Nihon Hinyokika Gakkai Zasshi; 1992 Mar; 83(3):374-82. PubMed ID: 1373458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.